Atlas Trials

Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies

Clinical trial NCT02711137 · TERMINATED

Trial details

NCT number
NCT02711137
Sponsor
Incyte Corporation
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Solid Tumors
Start date
2016-05-18
Primary completion
2019-02-13
Enrollment
137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.